Back
NuCana PLC 10K Form
Buy
60
NCNA
NuCana PLC
Last Price:
1.27
Seasonality Move:
11.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NCNA News And Ratings
See the #1 stock for the next 7 days that we like better than NCNA
NCNA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.57M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.14 |
| Price / Book: | 0.67 |
Profitability
| EPS (TTM): | -16.68010 |
|---|---|
| Net Income (TTM): | $-35.49M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
NuCana PLC Earnings Forecast
Key NuCana PLC Financial Ratios
- Per Share Earnings over the last 9 years have been positive in 3 years.
NuCana PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NCNA |
| CUSIP: | 67022C |
| Website: | nucana.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NCNA Technical Analysis vs Fundamental Analysis
Buy
60
NuCana PLC (NCNA)
is a Buy
Is NuCana PLC a Buy or a Sell?
-
NuCana PLC stock is rated a Buy
The current NuCana PLC [NCNA] share price is $1.28. The Score for NCNA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.